Comparison of vasopressin-first weaning versus norepinephrine-first weaning in critically ill patients.

IF 0.9 4区 医学 Q4 PHARMACOLOGY & PHARMACY
Maram Alshreef, Hanin AbaAlkhayl, Qoot Almdainy, Abdulaziz Alshammari, Shahad Alajmi, Shatha Alruwaite, Ebtisam Alqahtani, Reema Almalke, Tagreed Alonazi
{"title":"Comparison of vasopressin-first weaning versus norepinephrine-first weaning in critically ill patients.","authors":"Maram Alshreef, Hanin AbaAlkhayl, Qoot Almdainy, Abdulaziz Alshammari, Shahad Alajmi, Shatha Alruwaite, Ebtisam Alqahtani, Reema Almalke, Tagreed Alonazi","doi":"10.5414/CP204891","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Septic shock is a critical condition requiring vasopressor support and mechanical ventilation. The sequence of vasopressor weaning may affect clinical outcomes, such as mechanical ventilation duration and patient survival.</p><p><strong>Objectives: </strong>This study assesses how vasopressor weaning order affects hemodynamic stability, clinical outcomes, and the length of mechanical ventilation in critically ill septic shock patients.</p><p><strong>Materials and methods: </strong>A retrospective cohort study was conducted at Prince Sultan Military Medical City, Riyadh, Saudi Arabia, from January 2022 to December 2023. Critically ill adult patients receiving intravenous norepinephrine and vasopressin for septic shock and requiring mechanical ventilation were included. Patients were classified into two groups: vasopressin weaned first or norepinephrine weaned first. The duration of mechanical ventilation was the main outcome. These were secondary outcomes: mean arterial pressure (MAP) stability, 30-day and in-hospital mortality, length of stay (LOS) in the intensive care unit and hospital, and rates of reintubation.</p><p><strong>Results: </strong>Among 100 patients (mean age: 65.1 ± 19.7 years; 58% male), vasopressin was weaned first in 47 patients (47%) and norepinephrine first in 53 (53%). Patients extubated while on vasopressors (vasopressin weaned first) had a shorter median duration of mechanical ventilation (4 days) and lower odds of mortality (adjusted OR = 0.30, 95% CI: 0.09 - 0.98; p = 0.046) compared to those weaned off norepinephrine first. No significant differences were observed in reintubation rates or LOS.</p><p><strong>Conclusion: </strong>Weaning vasopressin before norepinephrine may be associated with improved survival and reduced mechanical ventilation duration in septic shock patients, although further research is needed to validate these findings and optimize vasopressor weaning strategies.</p>","PeriodicalId":13963,"journal":{"name":"International journal of clinical pharmacology and therapeutics","volume":" ","pages":"83-91"},"PeriodicalIF":0.9000,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12825015/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of clinical pharmacology and therapeutics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.5414/CP204891","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Septic shock is a critical condition requiring vasopressor support and mechanical ventilation. The sequence of vasopressor weaning may affect clinical outcomes, such as mechanical ventilation duration and patient survival.

Objectives: This study assesses how vasopressor weaning order affects hemodynamic stability, clinical outcomes, and the length of mechanical ventilation in critically ill septic shock patients.

Materials and methods: A retrospective cohort study was conducted at Prince Sultan Military Medical City, Riyadh, Saudi Arabia, from January 2022 to December 2023. Critically ill adult patients receiving intravenous norepinephrine and vasopressin for septic shock and requiring mechanical ventilation were included. Patients were classified into two groups: vasopressin weaned first or norepinephrine weaned first. The duration of mechanical ventilation was the main outcome. These were secondary outcomes: mean arterial pressure (MAP) stability, 30-day and in-hospital mortality, length of stay (LOS) in the intensive care unit and hospital, and rates of reintubation.

Results: Among 100 patients (mean age: 65.1 ± 19.7 years; 58% male), vasopressin was weaned first in 47 patients (47%) and norepinephrine first in 53 (53%). Patients extubated while on vasopressors (vasopressin weaned first) had a shorter median duration of mechanical ventilation (4 days) and lower odds of mortality (adjusted OR = 0.30, 95% CI: 0.09 - 0.98; p = 0.046) compared to those weaned off norepinephrine first. No significant differences were observed in reintubation rates or LOS.

Conclusion: Weaning vasopressin before norepinephrine may be associated with improved survival and reduced mechanical ventilation duration in septic shock patients, although further research is needed to validate these findings and optimize vasopressor weaning strategies.

Abstract Image

Abstract Image

Abstract Image

危重患者血管加压素优先脱机与去甲肾上腺素优先脱机比较。
背景:脓毒性休克是一种危重疾病,需要血管加压剂支持和机械通气。血管加压素脱机的顺序可能影响临床结果,如机械通气时间和患者生存。目的:本研究评估危重感染性休克患者升压药物脱机顺序对血流动力学稳定性、临床结果和机械通气时间的影响。材料和方法:于2022年1月至2023年12月在沙特阿拉伯利雅得苏丹王子军事医疗城进行了一项回顾性队列研究。危重成人患者接受静脉注射去甲肾上腺素和加压素治疗感染性休克并需要机械通气。患者分为两组:先停用抗利尿激素或先停用去甲肾上腺素。机械通气时间是主要观察指标。这些是次要结局:平均动脉压(MAP)稳定性、30天和住院死亡率、在重症监护病房和医院的住院时间(LOS)以及再插管率。结果:100例患者(平均年龄:65.1±19.7岁,男性58%)中,抗利尿激素优先断奶47例(47%),去甲肾上腺素优先断奶53例(53%)。与先停用去甲肾上腺素的患者相比,拔管同时使用血管加压素(先停用血管加压素)的患者机械通气的中位持续时间(4天)更短,死亡率更低(调整后OR = 0.30, 95% CI: 0.09 - 0.98; p = 0.046)。在再插管率和LOS方面没有观察到显著差异。结论:在使用去甲肾上腺素之前停用抗利尿激素可能与脓毒性休克患者的生存率提高和机械通气时间缩短有关,尽管需要进一步的研究来验证这些发现并优化抗利尿激素的停用策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
1.70
自引率
12.50%
发文量
116
审稿时长
4-8 weeks
期刊介绍: The International Journal of Clinical Pharmacology and Therapeutics appears monthly and publishes manuscripts containing original material with emphasis on the following topics: Clinical trials, Pharmacoepidemiology - Pharmacovigilance, Pharmacodynamics, Drug disposition and Pharmacokinetics, Quality assurance, Pharmacogenetics, Biotechnological drugs such as cytokines and recombinant antibiotics. Case reports on adverse reactions are also of interest.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书